<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.herbalscienceresearch.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Herbal Science Research - prevention</title>
 <link>http://www.herbalscienceresearch.com/taxonomy/term/94/0</link>
 <description></description>
 <language>en</language>
<item>
 <title>Moving toward bioadjuvant approaches to head and neck cancer prevention.</title>
 <link>http://www.herbalscienceresearch.com/node/795</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=17848282&amp;amp;dopt=Abstract&quot;&gt;Moving toward bioadjuvant approaches to head and neck cancer prevention.&lt;/a&gt;: Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S132-5  Authors:  Saba NF, Hammond A, Shin DM, Khuri FR&lt;/p&gt;
&lt;p&gt;Head and neck squamous cell carcinoma affects &amp;gt;45,000 Americans annually. Patients who are successfully treated for their primary tumor are at high risk of developing a second primary tumor, making effective preventive strategies highly desirable for this disease. Although a landmark study in 1990 suggested some benefit of high-dose retinoids in head and neck cancer prevention, subsequent trials using more tolerable doses have shown limited clinical success. Newer preventive strategies have included bioadjuvant therapy combining retinoids with interferon and alpha-tocopherol, combinations of molecularly targeted agents, and oncolytic viruses. Furthermore, considerable evidence has supported a cancer protective role for several nutrients, including green tea and curcumin analogs. Natural compounds such as these with favorable long-term safety profiles might be particularly suited to the cancer prevention setting, in which patients will usually tolerate only moderate risk and toxicity.&lt;/p&gt;
&lt;p&gt;PMID: 17848282 [PubMed - in process]&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/cancer">cancer</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <pubDate>Mon, 22 Oct 2007 18:27:34 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">795 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Prevention and treatment of vaginal bleeding after drug-induced abortion by Yaoliuan capsule and its effects on menses recovery.</title>
 <link>http://www.herbalscienceresearch.com/node/757</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16201292&amp;amp;dopt=Abstract&quot;&gt;Prevention and treatment of vaginal bleeding after drug-induced abortion by Yaoliuan capsule and its effects on menses recovery.&lt;/a&gt;: J Huazhong Univ Sci Technolog Med Sci. 2005;25(3):346-7, 367  Authors:  Jin Z, Huang G&lt;/p&gt;
&lt;p&gt;In order to explore the effect of Yaoliuan capsule in the prevention and treatment of vaginal bleeding after drug-induced abortion and menses recovery after drug-induced abortion, 323 cases of gestation period &amp;lt; or = 49 days and without contraindication, were divided randomly into study group (168 cases, taking Yaoliuan capsule) and control group (155 cases, taking placebo capsule). The results showed that in the study group, there were 161 cases (95.8%) of complete abortion, 7 cases (4.2%) of incomplete abortion; In the control group, there were 146 cases (94.2%) of complete abortion, 6 cases (3.9%) of incomplete abortion, 3 cases (1.9%) of abortion failure. The vaginal bleeding time was 5-25 days (mean 10.8 days) in study group, while that was 6-62 days (mean 19.1 days) in control group. The menstrual cycle was 30.5+/-5. 2 days and 33.8 d+/-8.6 days respectively in study and control groups. The menstrual period was 6.1+/-3. 5 days and 9.9+/-5.1 days respectively in study and control groups. Yaoliuan capsule is an effective drug to prevent and treat vaginal bleeding following drug-induced abortion, promote menstruation recovery and prevent pelvic infection.&lt;/p&gt;
&lt;p&gt;PMID: 16201292 [PubMed - indexed for MEDLINE]&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/pregnancy">pregnancy</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/women">women</category>
 <pubDate>Thu, 04 Oct 2007 05:20:47 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">757 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis.</title>
 <link>http://www.herbalscienceresearch.com/node/706</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.hubmed.org/display.cgi?uids=17597571&quot;&gt;Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis.&lt;/a&gt;: Lancet Infect Dis. 2007 Jul; 7(7): 473-80  Shah SA, Sander S, White CM, Rinaldi M, Coleman CI
&lt;p&gt;Echinacea is one of the most commonly used herbal products, but controversy exists about its benefit in the prevention and treatment of the common cold. Thus, we did a meta-analysis evaluating the effect of echinacea on the incidence and duration of the common cold. 14 unique studies were included in the meta-analysis. Incidence of the common cold was reported as an odds ratio (OR) with 95% CI, and duration of the common cold was reported as the weighted mean difference (WMD) with 95% CI. Weighted averages and mean differences were calculated by a random-effects model (DerSimonian-Laird methodology). Heterogeneity was assessed by the Q statistic and review of L&#039;Abb&amp;eacute; plots, and publication bias was assessed through the Egger weighted regression statistic and visual inspection of funnel plots. Echinacea decreased the odds of developing the common cold by 58% (OR 0.42; 95% CI 0.25-0.71; Q statistic p&lt;0.001) and the duration of a cold by 1.4 days (WMD -1.44, -2.24 to -0.64; p=0.01). Similarly, significant reductions were maintained in subgroup analyses limited to Echinaguard/Echinacin use, concomitant supplement use, method of cold exposure, Jadad scores less than 3, or use of a fixed-effects model. Published evidence supports echinacea&#039;s benefit in decreasing the incidence and duration of the common cold.&lt;br /&gt;
&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/immunity">immunity</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/meta-analysis">meta-analysis</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/respiratory">respiratory</category>
 <pubDate>Fri, 13 Jul 2007 18:40:51 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">706 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence.</title>
 <link>http://www.herbalscienceresearch.com/node/699</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=17194528&amp;amp;dopt=Abstract&quot;&gt;Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence.&lt;/a&gt;: Cancer Lett. 2007 Jun 18;251(1):43-52  Authors:  Ye B, Aponte M, Dai Y, Li L, Ho MC, Vitonis A, Edwards D, Huang TN, Cramer DW&lt;/p&gt;
&lt;p&gt;There is considerable interest in herbal therapies for cancer prevention but often with little scientific evidence to support their use. In this study, we examined epidemiological data regarding effects of commonly used herbal supplements on risk for ovarian cancer and sought supporting biological evidence. 4.2% of 721 controls compared to 1.6% of 668 cases regularly used Ginkgo biloba for an estimated relative risk (and 95% confidence interval) of 0.41 (0.20,0.84) (p=0.01); and the effect was most apparent in women with non-mucinous types of ovarian cancer, RR=0.33 (0.15,0.74) (p=0.007). In vitro experiments with normal and ovarian cancer cells showed that Ginkgo extract and its components, quercetin and ginkgolide A and B, have significant anti-proliferative effects ( approximately 40%) in serous ovarian cancer cells, but little effect in mucinous (RMUG-L) cells. For the ginkgolides, the inhibitory effect appeared to be cell cycle blockage at G0/G1 to S phase. This combined epidemiological and biological data provide supportive evidence for further studies of the chemopreventive or therapeutic effects of Ginkgo and ginkgolides on ovarian cancer.&lt;/p&gt;
&lt;p&gt;PMID: 17194528 [PubMed - indexed for MEDLINE]&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/cancer">cancer</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/epidemiologic">epidemiologic</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/women">women</category>
 <pubDate>Fri, 13 Jul 2007 18:22:25 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">699 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>[Prevention and alternative methods for prophylaxis of recurrent urinary tract infections in women]</title>
 <link>http://www.herbalscienceresearch.com/node/675</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16541289&amp;amp;dopt=Abstract&quot;&gt;[Prevention and alternative methods for prophylaxis of recurrent urinary tract infections in women]&lt;/a&gt;: Urologe A. 2006 Apr;45(4):443-4, 446-50  Authors:  Vahlensieck W, Bauer H&lt;/p&gt;
&lt;p&gt;General recommendations to prevent recurrent urinary tract infections (rUTI) result in about one-third of patients remaining free of recurrences. Oral and parenteral immunotherapy were effective in several controlled studies for prevention of rUTI. These therapies can be combined with acute antibiotic therapy. Vaginal prophylaxis with oestriol has proven its positive effect without serious gynaecological side effects. Also there is increasing evidence that cranberries prevent rUTI. The exact mode (juice, tablets or preserved berries), dosage and duration of this therapy remain to be defined. There are also promising therapy modalities such as changing bacterial gut flora, general immune response (acupuncture, inpatient rehabilitation) and urine acidity.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/gastrointestinal">gastrointestinal</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/immunity">immunity</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/urinary">urinary</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/women">women</category>
 <pubDate>Mon, 11 Jun 2007 06:43:56 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">675 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice.</title>
 <link>http://www.herbalscienceresearch.com/node/627</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=17465224&amp;amp;dopt=Abstract&quot;&gt;Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice.&lt;/a&gt;: Anticancer Res. 2007 Mar-Apr;27(2):937-48  Authors:  Boivin D, Blanchette M, Barrette S, Moghrabi A, B&amp;eacute;liveau R&lt;/p&gt;
&lt;p&gt;BACKGROUND: Berries contain several phytochemicals, such as phenolic acids, proanthocyanidins, anthocyanins and other flavonoids. There has been growing interest in a variety of potential chemopreventive activities of edible berries. The potential chemopreventive activity of a variety of small berries cultivated or collected in the province of Qu&amp;eacute;bec, Canada were evaluated here. MATERIALS AND METHODS: Strawberry, raspberry, black currant, red currant, white currant, gooseberry, high-bush blueberry, low-bush blueberry, velvet leaf blueberry, serviceberry, blackberry, black chokeberry, sea buckthorn and cranberry were evaluated for antioxidant capacity, anti-proliferative activity, anti-inflammatory activity, induction of apoptosis and cell cycle arrest. RESULTS: The growth of various cancer cell lines, including those of stomach, prostate, intestine and breast, was strongly inhibited by raspberry, black currant, white currant, gooseberry, velvet leaf blueberry, low-bush blueberry, sea buckthorn and cranberry juice, but not (or only slightly) by strawberry, high-bush blueberry, serviceberry, red currant, or blackberry juice. No correlation was found between the anti-proliferative activity of berry juices and their antioxidant capacity (p &amp;gt; 0.05). The inhibition of cancer cell proliferation by berry juices did not involve caspase-dependent apoptosis, but appeared to involve cell-cycle arrest, as evidenced by down-regulation of the expression of cdk4, cdk6, cyclin D1 and cyclin D3. Of the 13 berries tested, juice of 6 significantly inhibited the TNF-induced activation of COX-2 expression and activation of the nuclear transcription factor NFkappaB. CONCLUSION: These results illustrate that berry juices have striking differences in their potential chemopreventive activity and that the inclusion of a variety of berries in the diet might be useful for preventing the development of tumors.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/antioxidant">antioxidant</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/cancer">cancer</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/nutrition">nutrition</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <pubDate>Fri, 25 May 2007 02:31:01 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">627 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Dietary supplements for the prevention and treatment of coronary artery disease.</title>
 <link>http://www.herbalscienceresearch.com/node/621</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=17309382&amp;amp;dopt=Abstract&quot;&gt;Dietary supplements for the prevention and treatment of coronary artery disease.&lt;/a&gt;: J Altern Complement Med. 2007 Jan-Feb;13(1):83-95  Authors:  Knox J, Gaster B&lt;/p&gt;
&lt;p&gt;PURPOSE: With the recent growth in the use of dietary supplements, it is increasingly important for clinicians to be familiar with the evidence for and against their efficacy. We set out to systematically review the dietary supplements available for the prevention and treatment of coronary artery disease. METHODS: Between May 2004 and May 2006, we searched MEDLINE, the Cochrane Library, and Pro-Quest using the MeSH terms hypertension, hypercholesterolemia, myocardial infarction, dietary supplements, and herb-drug interactions. The MeSH terms of individual supplements identified were then added to the search. Reference lists of pertinent papers were also searched to find appropriate papers for inclusion. We included randomized controlled trials published in English of at least 1 week&#039;s duration that studied the efficacy of supplements in the treatment of hypercholesterolemia, or hypertension, or in the prevention of cardiac events. Qualifying papers were identified and assigned a Jadad quality score. In areas of uncertainty, a second investigator independently scored the trial. RESULTS: Fifteen (15) supplements were identified. Of these, most had little data available and most of the data were of poor quality. The supplements with the most supporting data were policosanol and garlic, both for hyperlipidemia. CONCLUSIONS: A growing body of literature exists for numerous supplements in the prevention of coronary artery disease, but much of these data are inconclusive. Clinicians should become familiar with the extent and limitations of this literature so that they may counsel their patients better.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/cardiovascular">cardiovascular</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <pubDate>Fri, 25 May 2007 02:24:58 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">621 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells...</title>
 <link>http://www.herbalscienceresearch.com/node/517</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16463383&amp;amp;dopt=Abstract&quot;&gt;Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene.&lt;/a&gt;: Int J Cancer. 2006 Jul 1;119(1):33-40 Authors:  Suganuma M, Kurusu M, Suzuki K, Tasaki E, Fujiki H&lt;/p&gt;
&lt;p&gt;To more clearly understand the molecular mechanisms involved in synergistic enhancement of cancer preventive activity with the green tea polyphenol (-)-epigallocatechin gallate (EGCG), we examined the effects of cotreatment with EGCG plus celecoxib, a cyclooxygenase-2 selective inhibitor. We specifically looked for induction of apoptosis and expression of apoptosis related genes, with emphasis on growth arrest and DNA damage-inducible 153 (GADD153) gene, in human lung cancer cell line PC-9: Cotreatment with EGCG plus celecoxib strongly induced the expression of both GADD153 mRNA level and protein in PC-9 cells, while neither EGCG nor celecoxib alone did. However, cotreatment did not induce expression of other apoptosis related genes, p21(WAF1) and GADD45. Judging by upregulation of GADD153, only cotreatment with EGCG plus celecoxib synergistically induced apoptosis of PC-9 cells. Synergistic effects with the combination were also observed in 2 other lung cancer cell lines, A549 and ChaGo K-1. Furthermore, EGCG did not enhance GADD153 gene expression or apoptosis induction in PC-9 cells in combination with N-(4-hydroxyphenyl)retinamide or with aspirin. Thus, upregulation of GADD153 is closely correlated with synergistic enhancement of apoptosis with EGCG. Cotreatment also activated the mitogen-activated protein kinases (MAPKs), such as ERK1/2 and p38 MAPK: Preteatment with PD98059 (ERK1/2 inhibitor) and UO126 (selective MEK inhibitor) abrogated both upregulation of GADD153 and synergistic induction of apoptosis of PC-9 cells, while SB203580 (p38 MAPK inhibitor) did not do so, indicating that GADD153 expression was mediated through the ERK signaling pathway. These findings indicate that high upregulation of GADD153 is a key requirement for cancer prevention in combination with EGCG.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/cancer">cancer</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/herbal">herbal</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/nutrition">nutrition</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/respiratory">respiratory</category>
 <pubDate>Tue, 09 Jan 2007 06:31:59 -0800</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">517 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Plasma Phytoestrogens and Subsequent Breast Cancer Risk.</title>
 <link>http://www.herbalscienceresearch.com/node/491</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=17200150&amp;amp;dopt=Abstract&quot;&gt;Plasma Phytoestrogens and Subsequent Breast Cancer Risk.&lt;/a&gt;: J Clin Oncol. 2007 Jan 2; Authors:  Verheus M, van Gils CH, Keinan-Boker L, Grace PB, Bingham SA, Peeters PH&lt;/p&gt;
&lt;p&gt;PURPOSE: Phytoestrogens are plant compounds that are structurally and functionally similar to mammalian estrogens. By competing for estrogen receptors, phytoestrogens possibly inhibit binding of the more potent endogenous estrogens and decrease their potential effects on breast cancer risk. We investigated the association between plasma phytoestrogen levels and breast cancer risk in a prospective manner. PATIENTS AND METHODS: We performed a nested case-control study within the Prospect cohort, one of the two Dutch cohorts participating in the European Prospective Investigation into Cancer and Nutrition. A total of 383 women (87 pre- or perimenopausal women [mean age, 52 years] and 296 postmenopausal women [mean age, 59 years]) who developed breast cancer were selected as case subjects and were matched to 383 controls, on date of blood sampling. Plasma levels of isoflavones (daidzein, genistein, glycitein, O-desmethylangolensin, and equol) and lignans (enterodiol and enterolactone) were measured. The isotope dilution liquid chromatography/tandem mass-spectrometry method incorporating triply (13)C-labeled standards was used for all analyses. Breast cancer odds ratios were calculated for tertiles of phytoestrogen plasma levels using conditional logistic regression analysis. RESULTS: For genistein, the risk estimate for the highest versus the lowest tertile was 0.68 (95% CI, 0.47 to 0.98). Similar protective effects, although not statistically significant, were seen for the other isoflavones. Lignan levels did not appear to be related to breast cancer risk. Results were the same in pre- or perimenopausal women, and in postmenopausal women. CONCLUSION: High genistein circulation levels are associated with reduced breast cancer risk in the Dutch population. No effects of lignans on breast cancer risk were observed.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/cancer">cancer</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/cohort-study">cohort study</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/herbal">herbal</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/phytoestrogen">phytoestrogen</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/women">women</category>
 <pubDate>Thu, 04 Jan 2007 18:06:21 -0800</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">491 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>In vitro determination of the contraceptive spermicidal activity of a composite extract of Achyranthes aspera and Stephania...</title>
 <link>http://www.herbalscienceresearch.com/node/451</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16472572&amp;amp;dopt=Abstract&quot;&gt;In vitro determination of the contraceptive spermicidal activity of a composite extract of Achyranthes aspera and Stephania hernandifolia on human semen.&lt;/a&gt;: Contraception. 2006 Mar;73(3):284-8  Authors:  Paul D, Bera S, Jana D, Maiti R, Ghosh D&lt;/p&gt;
&lt;p&gt;OBJECTIVE: To evaluate the effect of a 50% ethanolic extract of the leaf of Stephania hernandifolia and the root of Achyranthes aspera on sperm motility and function in a ratio of 1:3 by weight at different concentrations. RESULTS: Concentration of 0.08 g/mL of the extract affected the motility, and at a concentration of 0.16 g/mL, the sperm motility was reduced to 20% immediately (within 20 s). At a concentration of 0.32 g/mL, this composite extract showed the most promising results by complete sperm immobilization within 2 min after the application of the extract. The effects were spermicidal but not spermiostatic as sperm immobilization effect was found to be irreversible. Sperm viability was decreased significantly and was found to be nonviable after 30 min when treated with the composite extract at a concentration of 0.32 g/mL. The hypo-osmotic swelling of these sperm was reduced significantly at this highest concentration, indicating that the crude extract may probably cause injury to the sperm plasma membrane. A low concentration of 0.04 g/mL is ineffective. CONCLUSION: The findings indicate that this composite plant extract possesses potential contraceptive spermicidal activity in vitro.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/herbal">herbal</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/in-vitro">in vitro</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/pregnancy">pregnancy</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <pubDate>Thu, 05 Oct 2006 18:37:40 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">451 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Postcoital ingestion of the aqueous extract of Erythrina falcata Benth prevents pregnancy in the mouse.</title>
 <link>http://www.herbalscienceresearch.com/node/446</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16472575&amp;amp;dopt=Abstract&quot;&gt;Postcoital ingestion of the aqueous extract of Erythrina falcata Benth prevents pregnancy in the mouse.&lt;/a&gt;: Contraception. 2006 Mar;73(3):307-10 Authors:  Orihuela PA, Ishiyama V&lt;/p&gt;
&lt;p&gt;AIM: We examined whether the aqueous extract of Erythrina falcata, reputed to be a contraceptive in Peruvian folklore, could prevent pregnancy in the mouse. METHODS: Female mice on Day 1 of pregnancy were given aqueous extract of E. falcata or tap water (control) orally for 4 days. On Day 4 of pregnancy, animals were killed and the embryos were flushed from oviducts and uterus to examine their developmental stage, cell number, mitotic index and micronuclei frequency. Other mice were killed on Day 12 of pregnancy to determine the number of implantation sites. RESULTS: Ingestion of E. falcata diminished the percentage of embryos that progressed to blastocyst stage, reduced the cell number and mitotic index, and increased the micronuclei frequency of early embryos. The number of implantation sites was also reduced in females treated with E. falcata. CONCLUSION: The aqueous extract of E. falcata, ingested during early pregnancy, disturbs preimplantation embryo development and implantation in the mouse. These results provide the first experimental evidence of the contraceptive properties of the aqueous extract of E. falcata.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/herbal">herbal</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/pregnancy">pregnancy</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <pubDate>Thu, 05 Oct 2006 18:28:13 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">446 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Protective effects of tea polyphenols and caffeine.</title>
 <link>http://www.herbalscienceresearch.com/node/410</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16336097&amp;amp;dopt=Abstract&quot;&gt;Protective effects of tea polyphenols and caffeine.&lt;/a&gt;: Expert Rev Anticancer Ther. 2005 Dec;5(6):1061-8  Authors:  Camouse MM, Hanneman KK, Conrad EP, Baron ED&lt;/p&gt;
&lt;p&gt;Compounds derived from botanical sources, such as polyphenols from tea, have been of interest as possible therapeutic agents. Their benefits in terms of cancer chemoprevention have also been investigated primarily through in vitro and animal in vivo studies. Ultraviolet light from solar radiation has been proven to initiate and promote skin cancer, which is the most common malignancy in light-skinned populations. This review discusses the effects of tea polyphenols in preventing cutaneous carcinogenesis. Although many of the mechanisms and pathways discussed may be applicable to other carcinogens, this review focuses mainly on those related to ultraviolet light-induced processes and potential action sites for tea polyphenols. Since caffeine is a component of tea, and has also been suggested as a possible chemoprotective agent, it is included in this review. Based on data from numerous studies published in the scientific literature, tea polyphenols are promising chemopreventive agents against ultraviolet-induced skin cancers. Their antioxidant properties, inhibitory effects on signal transduction pathways, cell proliferation, angiogenesis and capacity for apoptosis induction, as well as possible immune protective effects, are among the mechanisms that contribute to skin cancer prevention.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/cancer">cancer</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/herbal">herbal</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/nutrition">nutrition</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/skin">skin</category>
 <pubDate>Fri, 09 Jun 2006 07:24:12 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">410 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>An adjunctive preventive treatment for cancer: Ultraviolet light and ginkgo biloba...</title>
 <link>http://www.herbalscienceresearch.com/node/402</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16483725&amp;amp;dopt=Abstract&quot;&gt;An adjunctive preventive treatment for cancer: Ultraviolet light and ginkgo biloba, together with other antioxidants, are a safe and powerful, but largely ignored, treatment option for the prevention of cancer.&lt;/a&gt;: Med Hypotheses. 2006 Feb 14;  Authors:  Eli R, Fasciano JA&lt;/p&gt;
&lt;p&gt;Cancer has surpassed heart disease as the leading cause of death in the United States. The mortality rate for cancer is high (roughly 42%), and it increases dramatically with increasing age, especially in patients between the ages of 40 and 60 years old. Currently, the efforts at cancer prevention have been minimal. The drugs developed so far are expensive and have serious side effects. There are at least 18 vitamin D-sensitive cancers. Ultraviolet light, and specifically ultraviolet B (UVB), could reduce cancer by the limited exposure of suitable skin areas to UVB of an intensity and duration insufficient to produce skin cancer. An irrational fear of skin cancer is preventing this idea from being implemented. Though skin cancer incidence is significant, mortality from skin cancer is relatively rare. Roughly 1,000,000 Americans will be affected by skin cancer but only 10,000 deaths are expected in 2005 (a 1% mortality rate). Skin cancer is easily detected and often cured by excisional biopsy alone. Current practice among practicing clinicians is to use a prescription drug substitute for UV light, calcitriol (1-25 dihydroxycholcalciferol). However, high levels of (calcitriol) are dangerous, and there is no consensus on just what a high dose or a safe dose is. Apart from skin cancer, UV light exposure possesses few risks. Additionally, a number of botanical agents such as ginkgo biloba, vitamins E and C, carotenoids, selenium and proanthocyanidins can prevent the risk of skin cancer. Ginkgo biloba also possess the following additional cancer chemopreventive qualities: (1) promoting apoptosis of cancer cells; (2) an anti-clastogenic effect on chromosomes by repairing and reconstituting broken and damaged chromosomes; (3) a powerful therapeutic effect on the treatment of fibrosis-related cancer; (4) a therapeutic effect on free radical-induced cancer; (5) a therapeutic effect on the treatment of cancer incident to the result of numerous carcinogens; (6) a therapeutic effect on preventing free radical-induced cancer; (7) an enhancing effect on radiation therapy in the treatment of cancer; and (8) a therapeutic effect on reducing the size of cancer tumors. Ginkgo biloba is widely-used and has few adverse effects. The proposed preventive treatment for cancer consists of short intermittent exposure of the least sensitive areas of the body to sunlight and/or artificial ultraviolet light. The routine testing of plasma vitamin D levels help monitor the effectiveness of the treatment and periodic checkups with a dermatologist help monitor the safety.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/antioxidant">antioxidant</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/cancer">cancer</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/herbal">herbal</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <pubDate>Fri, 09 Jun 2006 07:22:32 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">402 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Epidemiology of insomnia: Prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors.</title>
 <link>http://www.herbalscienceresearch.com/node/382</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16459140&amp;amp;dopt=Abstract&quot;&gt;Epidemiology of insomnia: Prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors.&lt;/a&gt;: Sleep Med. 2006 Feb 1; Authors:  Morin CM, Leblanc M, Daley M, Gregoire JP, M&amp;eacute;rette C&lt;/p&gt;
&lt;p&gt;BACKGROUND AND PURPOSE: To estimate the prevalence of insomnia symptoms and syndrome in the general population, describe the types of self-help treatments and consultations initiated for insomnia, and examine help-seeking determinants. PATIENTS AND METHODS: A randomly selected sample of 2001 French-speaking adults from the province of Quebec (Canada) responded to a telephone survey about sleep, insomnia, and its treatments. RESULTS: Of the total sample, 25.3% were dissatisfied with their sleep, 29.9% reported insomnia symptoms, and 9.5% met criteria for an insomnia syndrome. Thirteen percent of the respondents had consulted a healthcare provider specifically for insomnia in their lifetime, with general practitioners being the most frequently consulted. Daytime fatigue (48%), psychological distress (40%), and physical discomfort (22%) were the main determinants prompting individuals with insomnia to seek treatment. Of the total sample, 15% had used at least once herbal/dietary products to facilitate sleep and 11% had used prescribed sleep medications in the year preceding the survey. Other self-help strategies employed to facilitate sleep included reading, listening to music, and relaxation. CONCLUSIONS: These findings confirm the high prevalence of insomnia in the general population. While few insomnia sufferers seek professional consultations, many individuals initiate self-help treatments, particularly when daytime impairments such as fatigue become more noticeable. Improved knowledge of the determinants of help-seeking behaviors could guide the development of effective public health prevention and intervention programs to promote healthy sleep.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/epidemiologic">epidemiologic</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/herbal">herbal</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <pubDate>Fri, 09 Jun 2006 07:18:13 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">382 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>A potential role of the curry spice curcumin in Alzheimer&#039;s disease.</title>
 <link>http://www.herbalscienceresearch.com/node/280</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=15974909&amp;amp;dopt=Abstract&quot;&gt;A potential role of the curry spice curcumin in Alzheimer&#039;s disease.&lt;/a&gt;: Curr Alzheimer Res. 2005 Apr;2(2):131-6 Authors:  Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL&lt;/p&gt;
&lt;p&gt;There is substantial in-vitro data indicating that curcumin has antioxidant, anti-inflammatory, and anti-amyloid activity. In addition, studies in animal models of Alzheimer&#039;s disease (AD) indicate a direct effect of curcumin in decreasing the amyloid pathology of AD. As the widespread use of curcumin as a food additive and relatively small short-term studies in humans suggest safety, curcumin is a promising agent in the treatment and/or prevention of AD. Nonetheless, important information regarding curcumin bioavailability, safety and tolerability, particularly in an elderly population is lacking. We are therefore performing a study of curcumin in patients with AD to gather this information in addition to data on the effect of curcumin on biomarkers of AD pathology.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/alzheimers-disease">alzheimers disease</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/anti-inflammatory">anti-inflammatory</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/antioxidant">antioxidant</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <pubDate>Fri, 09 Jun 2006 04:17:46 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">280 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>[Protocatechuic acid in cancer prevention.]</title>
 <link>http://www.herbalscienceresearch.com/node/267</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16407799&amp;amp;dopt=Abstract&quot;&gt;[Protocatechuic acid in cancer prevention.]&lt;/a&gt;: Postepy Hig Med Dosw (Online). 2005;59:608-15  Authors:  Szumi&amp;#322;o J&lt;/p&gt;
&lt;p&gt;Protocatechuic acid (3,4-dihydroxybenzoic acid) is a natural phenolic compound found in many edible and medicinal plants. Recent studies indicate that it could be used as a protective agent against cardiovascular diseases and neoplasms. The mechanism of its action is mostly associated with antioxidant activity, including inhibition of generation as well as scavenging of free radicals and up-regulating enzymes which participate in their neutralization. The influence on phase I and II of some carcinogens&#039; metabolism and, perhaps, direct blocking of specific binding sites of ultimate carcinogens with DNA molecule, thus preventing adduct formation that may result in mutations and neoplastic transformation, are also important. However, the other aspects of the chemopreventive activity of protocatechuic acid including influence on the activity of inducible isoenzyme of cyclooxygenase and nitric oxide synthase or cell cycle regulating proteins are not fully evaluated.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/anti-inflammatory">anti-inflammatory</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/cancer">cancer</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/cardiovascular">cardiovascular</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/herbal">herbal</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <pubDate>Fri, 09 Jun 2006 04:14:16 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">267 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Consumption of Antioxidant-Rich Beverages and Risk for Breast Cancer in French Women.</title>
 <link>http://www.herbalscienceresearch.com/node/248</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16406814&amp;amp;dopt=Abstract&quot;&gt;Consumption of Antioxidant-Rich Beverages and Risk for Breast Cancer in French Women.&lt;/a&gt;: Ann Epidemiol. 2006 Jan 6;  Authors:  Hirvonen T, Mennen LI, de Bree A, Castetbon K, Galan P, Bertrais S, Arnault N, Hercberg S&lt;/p&gt;
&lt;p&gt;PURPOSE: The objective of the study is to evaluate the relation between antioxidant-rich beverages and the incidence of breast cancer. METHODS: This prospective study consisted of 4396 women without a history of cancer who were participants in the French Suppl&amp;eacute;mentation en Vitamines et Min&amp;eacute;raux Antioxydants Study. Beverage consumption was estimated by using three nonconsecutive 24-hour recalls. Incident cancer cases were identified through clinical examinations performed every other year, including, e.g., a screening mammogram, and through a monthly health questionnaire. RESULTS: During the median 6.6 years of follow-up, 95 breast cancers were diagnosed. In a multivariate model, an inverse association between herbal tea consumption and risk for breast cancer was observed (compared with nondrinkers, drinking 1 to 149 mL/d; relative risk [RR], 0.93; 95% confidence interval [CI], 0.48-1.80, and for &amp;gt;/=150 mL/d; RR, 0.43; 95% CI, 0.20-0.94; p for trend=0.04). Consumption of coffee, tea, fruit juices, or wine was not associated with risk for breast cancer. CONCLUSION: Results of this study suggest that consumption of herbal tea may have a role in the prevention of breast cancer.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/antioxidant">antioxidant</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/cancer">cancer</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/clinical-trial">clinical trial</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/nutrition">nutrition</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/women">women</category>
 <pubDate>Fri, 09 Jun 2006 04:07:55 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">248 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Nutrition and primary prevention of breast cancer: foods, nutrients and breast cancer risk.</title>
 <link>http://www.herbalscienceresearch.com/node/58</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16316809&amp;amp;dopt=Abstract&quot;&gt;Nutrition and primary prevention of breast cancer: foods, nutrients and breast cancer risk.&lt;/a&gt; - Eur J Obstet Gynecol Reprod Biol. 2005 Dec 1;123(2):139-49&amp;nbsp; Authors: Hanf V, Gonder U
&lt;p&gt;Worldwide, each year approximately one million women are newly diagnosed with breast cancer (BC), in Germany 65 new cases per 100,000 inhabitants are registered, yearly. The fact that incidence has been rising in parallel with economic development indicates that environmental factors might play a role in the causation of BC. Migrational data have pointed to nutrition as one of the more relevant external factors involved. Preventive dietary advice often includes a reduction of alcohol, red meat and animal fat and increasing the intake of vegetables, fruit and fibre and lately, phytoestrogens from various sources. Clearly, the scientific basis for these recommendations appears sparse. The available prospective data from epidemiological studies and interventional trials do not support the overall hypothesis that higher fat-intakes are a relevant risk factor for BC development, more important seems the relative distribution of various fatty acids. A non-vegetarian eating habit (consumption of animal products) per se does not elevate BC risk, while consumption of broiled or deep fried meats cannot be ruled out as a risk factor in genetically susceptible individuals. It appears prudent to abstain from regular and increased alcohol consumption. This should be particularly true for pubescent girls, in whom glandular breast tissue is particularly vulnerable. In general, if alcohol is consumed on a regular basis, a sufficient supply of fresh vegetables and fruit is essential. While there is no overall protective effect of a high fruit and vegetable consumption speculation remains over possible beneficial effects of certain subcategories, especially brassica vegetables like broccoli, cauliflower and cabbage. In essence, regional differences in BC incidence are probably partially attributable to life long dietary habits. There is no need to adopt a foreign dietary plan in order to protect oneself against BC. Traditional western diets also have their beneficial ingredients that should be regular constituents in our meals. Lignans from traditionally made sourdough rye bread, linseed/flaxseed and berries are local sources of potentially canceroprotective phyto-estrogens. Furthermore, indole-3-carbinol rich cabbage species might contribute to BC protection by diet. Nevertheless, clear cut recommendations for or against single nutrients or secondary plant metabolites are not yet possible, lacking sufficient data on individual bioavailability, safety and long term outcome. BC prevention by dietary means therefore relies on an individually tailored mixed diet, rich in basic foods and traditional manufacturing and cooking methods.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/cancer">cancer</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/herbal">herbal</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/nutrition">nutrition</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <pubDate>Fri, 09 Jun 2006 03:12:41 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">58 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism.</title>
 <link>http://www.herbalscienceresearch.com/node/34</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16289744&amp;amp;dopt=Abstract&quot;&gt;Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism.&lt;/a&gt; - Toxicol In Vitro. 2005 Nov 10;&amp;nbsp; Authors:  Moon YJ, Wang X, Morris ME
&lt;p&gt;Flavonoids are present in fruits, vegetables and beverages derived from plants (tea, red wine), and in many dietary supplements or herbal remedies including Ginkgo Biloba, Soy Isoflavones, and Milk Thistle. Flavonoids have been described as health-promoting, disease-preventing dietary supplements, and have activity as cancer preventive agents. Additionally, they are extremely safe and associated with low toxicity, making them excellent candidates for chemopreventive agents. The cancer protective effects of flavonoids have been attributed to a wide variety of mechanisms, including modulating enzyme activities resulting in the decreased carcinogenicity of xenobiotics. This review focuses on the flavonoid effects on cytochrome P450 (CYP) enzymes involved in the activation of procarcinogens and phase II enzymes, largely responsible for the detoxification of carcinogens. A number of naturally occurring flavonoids have been shown to modulate the CYP450 system, including the induction of specific CYP isozymes, and the activation or inhibition of these enzymes. Some flavonoids alter CYPs through binding to the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor, acting as either AhR agonists or antagonists. Inhibition of CYP enzymes, including CYP 1A1, 1A2, 2E1 and 3A4 by competitive or mechanism-based mechanisms also occurs. Flavones (chrysin, baicalein, and galangin), flavanones (naringenin) and isoflavones (genistein, biochanin A) inhibit the activity of aromatase (CYP19), thus decreasing estrogen biosynthesis and producing antiestrogenic effects, important in breast and prostate cancers. Activation of phase II detoxifying enzymes, such as UDP-glucuronyl transferase, glutathione S-transferase, and quinone reductase by flavonoids results in the detoxification of carcinogens and represents one mechanism of their anticarcinogenic effects. A number of flavonoids including fisetin, galangin, quercetin, kaempferol, and genistein represent potent non-competitive inhibitors of sulfotransferase 1A1 (or P-PST); this may represent an important mechanism for the chemoprevention of sulfation-induced carcinogenesis. Importantly, the effects of flavonoids on enzymes are generally dependent on the concentrations of flavonoids present, and the different flavonoids ingested. Due to the low oral bioavailability of many flavonoids, the concentrations achieved in vivo following dietary administration tend to be low, and may not reflect the concentrations tested under in vitro conditions; however, this may not be true following the ingestion of herbal preparations when much higher plasma concentrations may be obtained. Effects will also vary with the tissue distribution of enzymes, and with the species used in testing since differences between species in enzyme activities also can be substantial. Additionally, in humans, marked interindividual variability in drug-metabolizing enzymes occurs as a result of genetic and environmental factors. This variability in xenobiotic metabolizing enzymes and the effect of flavonoid ingestion on enzyme expression and activity can contribute to the varying susceptibility different individuals have to diseases such as cancer. As well, flavonoids may also interact with chemotherapeutic drugs used in cancer treatment through the induction or inhibition of their metabolism.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/cancer">cancer</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/cytochrome-p450">cytochrome p450</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/flavonoid">flavonoid</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/in-vitro">in vitro</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/isoflavone">isoflavone</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/nutrition">nutrition</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <pubDate>Fri, 09 Jun 2006 03:04:35 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">34 at http://www.herbalscienceresearch.com</guid>
</item>
<item>
 <title>Efficacy of aloe vera cream in prevention and treatment of sunburn and suntan.</title>
 <link>http://www.herbalscienceresearch.com/node/25</link>
 <description>&lt;p&gt;&lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&amp;amp;db=PubMed&amp;amp;cmd=Retrieve&amp;amp;list_uids=16623024&amp;amp;dopt=Abstract&quot;&gt;Efficacy of aloe vera cream in prevention and treatment of sunburn and suntan.&lt;/a&gt;: J Med Assoc Thai. 2005 Sep;88 Suppl 4:S173-6  Authors:  Puvabanditsin P, Vongtongsri R&lt;/p&gt;
&lt;p&gt;The efficacy of aloe vera cream in prevention of burn and tan from ultraviolet were studied in 20 volunteers. The minimal erythema dose of 20 volunteers were tested. The mean MED was 40-60 mj. The well preserved containing 70% of aloe vera cream. The aloe vera cream was applied randomized double blind technique on the test sites 30 minutes before, immediately after, or both before and after then the serial ultraviolet UVB 40,50,60,70,80 mj were radiated. MED reading at 24 hour for sunburn evaluation. Erythema and pigmentation were evaluated by visual grading 1-4 score. The aloe vera cream was continuing applied at the test sites twice daily for the the next three weeks. The results showed that the aloe vera cream has no sunburn or suntan protection and no efficacy in sunburn treatment when compared to placebo. The aloe vera cream has no bleaching effect too.&lt;/p&gt;
</description>
 <category domain="http://www.herbalscienceresearch.com/keyword/herbal">herbal</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/prevention">prevention</category>
 <category domain="http://www.herbalscienceresearch.com/keyword/skin">skin</category>
 <pubDate>Wed, 07 Jun 2006 10:33:27 -0700</pubDate>
 <dc:creator>Site Editor</dc:creator>
 <guid isPermaLink="false">25 at http://www.herbalscienceresearch.com</guid>
</item>
</channel>
</rss>
